{"title":"Do Ophthalmologists in India Over Prescribing Topical Antibiotics in Acute Infectious Conjunctivitis?","authors":"H. Kauser, R. Garg","doi":"10.19070/2332-290X-1900081","DOIUrl":null,"url":null,"abstract":"Inflammation or infection of the conjunctiva is known as conjunctivitis. It is characterized by dilatation of conjunctival vessels, hyperemia and edema of the conjunctiva and typically associated with discharge [1]. Conjunctivitis affects many people and imposes economic burden. Approximately 6 million people were affected annually with acute conjunctivitis in the United States [2]. The cost of treating bacterial conjunctivitis alone was estimated to be $377 million to $857 million per year [3]. Irrespective of the cause of conjunctivitis, in many US state health departments, students are required to be treated with topical antibiotic eye drops before returning to school [4].","PeriodicalId":90865,"journal":{"name":"International journal of ophthalmology & eye science","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of ophthalmology & eye science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19070/2332-290X-1900081","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Inflammation or infection of the conjunctiva is known as conjunctivitis. It is characterized by dilatation of conjunctival vessels, hyperemia and edema of the conjunctiva and typically associated with discharge [1]. Conjunctivitis affects many people and imposes economic burden. Approximately 6 million people were affected annually with acute conjunctivitis in the United States [2]. The cost of treating bacterial conjunctivitis alone was estimated to be $377 million to $857 million per year [3]. Irrespective of the cause of conjunctivitis, in many US state health departments, students are required to be treated with topical antibiotic eye drops before returning to school [4].